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Plenty New Under the Sun
Jonathan Rees1
Variation at the melanocortin 1 receptor (MC1R) is very common in most non-
African world populations. A range of variants predispose to skin cancer, including 
melanoma. What remains unclear are the mechanisms linking gene variation with 
sun sensitivity or tumor risk. In particular, it remains unclear whether pigmentary 
effects of the MC1R can account for all of the increase in cancer risk.
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The modern study of the genetics of 
normal human pigmentary variation is 
just over ten years old (Rees, 2003). The 
field may not yet be mature, but there 
is a clear feeling that the first few chap-
ters of this particular story can now be 
written: in broad outline we now know 
which genes account for most variation 
in human skin and hair color. The paper 
by Stratigos and colleagues (2006, this 
issue), in which melanocortin 1 recep-
tor (MC1R) variants have been studied 
in relation to pigmentary phenotype and 
melanoma, is a welcome addition to the 
literature — welcome, because most 
previous studies of pigmentary genetics 
have concentrated on northern rather 
than southern European populations, 
and because the paper highlights some 
of the uncertainties in our understand-
ing of the mechanisms by which MC1R 
variation affects phenotype.
The first modern study of the genet-
ics of red hair was carried out almost a 
century ago by the Davenports at what 
was then the Carnegie Institute and is 
now famous worldwide as Cold Spring 
Harbor Laboratory (reviewed by Rees, 
2003). The Davenports studied kindreds 
with red hair and suggested that the red-
hair trait approximated to an autosomal 
recessive. They were right, although not 
all subsequent work came to the same 
conclusion. The next seminal advance, 
following a few unsuccessful attempts 
at mapping the red-hair trait in humans, 
came from the marriage of mouse and 
molecular genetics. The genes underly-
ing a range of murine coat-color muta-
tions were cloned, and within years the 
genetic bases for some rare mendelian 
pigmentary syndromes in humans were 
identified. One gene, the melanocortin 
1 receptor, the subject of the study by 
Stratigos et al. (2006), was cloned in mice 
by Roger Cone’s group in 1993 (Robbins 
et al., 1993). Work in mice showed that 
signaling through this pathway led to an 
increase in the ratio of eumelanin to phe-
omelanin in hair (Robbins et al., 1993). 
Conversely, the absence of, or a reduc-
tion in, signaling, whether due to muta-
tion at the mc1r or absence of the ligand 
α-melanocyte-stimulating hormone, 
resulted in a relative overproduction of 
pheomelanin, leading to a yellow coat.
Shortly after Cone and colleagues’ 
work in mice, it was reported that most 
red-haired persons harbored homo-
zygous diminished-function alleles at 
the MC1R (Valverde et al., 1995). The 
human MC1R codes for a 317-amino 
acid G-coupled receptor, and many 
non-African human populations show a 
striking degree of variation at this locus 
(Wong and Rees, 2005). Over 75 differ-
ent MC1R alleles in humans have been 
identified (Wong and Rees, 2005), and 
Stratigos et al. (2006) show that even in 
a southern European population 38% 
of the control population shows MC1R 
variants. A striking feature of the MC1R 
is that a large number of the alleles 
appear to be quantitatively different in 
terms of function; that is, rather than all 
the alleles associated with red hair being 
complete loss-of-function alleles, they 
show varying degrees of signaling activ-
ity (Ringholm et al., 2004). Given that 
there is evidence for a clear additive (or 
dosage) effect among 0, 1, and 2 variant 
alleles, a range of physiological activ-
ity can arise from a single locus. MC1R 
heterozygotes are intermediate for hair 
eumelanin and pheomelanin ratios, and 
those with different shades of red hair 
appear to differ at the MC1R (Naysmith 
et al., 2004). Thus, although red hair 
approximates to an autosomal reces-
sive trait, the more closely one stud-
ies the phenotype, the more subtle the 
relation between particular alleles and 
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phenotype becomes. So if we ignore for 
one moment complex genetics (in which 
by definition the phenotype depends on 
many different loci), in the case of hair 
and skin color, nature can even fashion a 
graded series of responses from only one 
locus. That there are indeed many loci 
just adds to the richness of the system.
Stratigos and colleagues (2006) exam-
ined the relation between MC1R and 
melanoma. Previous studies predomi-
nantly in northern European popula-
tions have shown that MC1R alleles 
are risk factors for most forms of skin 
cancer, including melanoma (Palmer et 
al., 2000). An unresolved issue, how-
ever, is whether the mechanism of eleva-
tion of melanoma risk in those persons 
who harbor MC1R variants is solely 
accounted for in terms of pigmentation 
or whether alternative non-pigmentary 
pathways are involved. Indeed, in the 
study by Stratigos et al. (2006) the risk of 
melanoma could not be solely account-
ed for in terms of pigmentation. In other 
words, when pigmentation measures 
were factored into the regression equa-
tion, MC1R sequence was still a key 
explanatory variable. How can this be 
explained? First, α-melanocyte-stimulat-
ing hormone has a myriad of biological 
activities, and MC1R is expressed on a 
number of cell types other than mela-
noma. For instance, recent work has 
highlighted that the MC1R may be a key 
determinant of nociception (Mogil et al., 
2003). One popular view is that the asso-
ciation between MC1R and skin cancers 
is a result of inflammatory or immune 
mechanisms influencing tumorigenesis. 
It is suggested that such pathways are in 
addition to (or even instead of) the effects 
of MC1R on skin melanins. However, 
even the relation between MC1R and 
sun sensitivity is also far from clear. It 
has long been taught that persons with 
red hair, hair that is characterized by a 
relative increase in pheomelanin over 
eumelanin, show analogous changes in 
their skin. Work by Tony Thody in the 
1990s challenged this view, and a recent 
larger study has suggested that pigment 
switching between eumelanin and phe-
omelanin may be less important than the 
total amounts of melanins (Hennessy et 
al., 2005, and Thody, references therein). 
The mouse, and in particular follicular 
melanogenesis, may not therefore be 
a good guide to what is happening in 
the interfollicular skin. More studies in 
humans and better assays for melanin 
are needed.
Even though we may be uncertain 
as to the nature of the pathways link-
ing MC1R with cancer risk, surprising 
though it may seem, it is still possible to 
assess the relative quantitative contribu-
tions of such alternative pathways. In a 
critical study, Dwyer and colleagues 
studied a group of patients with mela-
noma and control subjects, and, besides 
carrying out MC1R sequencing, they 
also assayed the pigmentary phenotype 
by measuring skin reflectance on the 
upper inner arm (Dwyer et al., 2004). 
They then used a now fairly standard 
receiver operating characteristic (ROC) 
curve analysis to estimate how much 
information sequencing provided over 
and above that provided by skin color. 
They found that the additional informa-
tion provided by MC1R was greater for 
basal-cell carcinoma than for melano-
ma, but even for basal-cell carcinoma 
the amount of information provided was 
modest. So, if age and sex could predict 
42 of the 640 cases of basal-cell carcino-
ma expected in a cohort of 10,000 over 
10 years, skin reflectance allowed pre-
diction of a further 14 cases (56 in total), 
and adding in MC1R sequence would 
only add another two cases (58 in total). 
Why is this important to our interpreta-
tion of the data presented by Stratigos 
et al. (2006)? First, it suggests that any 
putative pathways linking MC1R varia-
tion and cancer risk (beyond skin color) 
are numerically small. Second, and 
of much greater importance, it serves 
to remind us that although we may 
identify and report modest odds ratios 
between genes and a disease state, 
in many instances we are perhaps an 
order of magnitude out in our ability to 
provide predictions of a future disease 
state that are meaningful for individual 
patients. So whereas our accumulating 
knowledge might gradually allow 
screening for melanoma to be consid-
ered, one has the feeling that there is a 
whole chunk of pigmentary biology that 
is still invisible to us. It seems, therefore, 
that some chapters of this particular story 
remain to be written.
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